The animals were also treated with either anti-PD-1 or anti-PD-L1 per the dosing scheduled described in Lussier et al.,20 starting 24 h after tumor inoculations and continued every third day for a total of four doses (Figure 3A). This evidence concerns the gene CD274 and neoplasm.